Guidewires Market Size Set to Reach Around USD 5 Bn by 2035

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Guidewires Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Guidewires Market

5.1. Covid-19: Guidewires Industry Impact
5.2. Guidewires Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Guidewires Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Guidewires Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Guidewires Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Product launches by key manufacturers
6.1.1.2. Increasing applications of guidewires
6.1.2. Market Restraints
6.1.2.1. High cost of surgical guidewires
6.1.3. Market Opportunities
6.1.3.1. Emerging applications

Chapter 7. Global Guidewires Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Guidewires Market Revenue by Market Players
7.1.1.2. Guidewires Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Guidewires Market, By Product

8.1. GuidewiresMarket, by Product
8.1.1. Coronary
8.1.1.1. Market Revenue and Forecast
8.1.2. Peripheral
8.1.2.1. Market Revenue and Forecast
8.1.3. Urology
8.1.3.1. Market Revenue and Forecast
8.1.4. Neurovascular
8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Guidewires Market, By Coating

9.1. Guidewires Market, by Coating
9.1.1. Coated
9.1.1.1. Market Revenue and Forecast
9.1.1.1.1. Hydrophilic
9.1.1.1.2. Hydrophobic
9.1.2. Non Coated
9.1.2.1. Market Revenue and Forecast

Chapter 10. Global Guidewires Market, By Raw Material

10.1. Guidewires Market, by Raw Material
10.1.1. Nitinol
10.1.1.1. Market Revenue and Forecast
10.1.2. Stainless Steel
10.1.2.1. Market Revenue and Forecast
10.1.3. Others
10.1.3.1. Market Revenue and Forecast

Chapter 11. Global Guidewires Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product
11.1.2. Market Revenue Forecast by Coating
11.1.3. Market Revenue Forecast by Raw Material
11.1.4. U.S
11.1.4.1. Market Revenue Forecast
11.1.5. Canada
11.1.5.1. Market Revenue Forecast
11.2. Europe
11.2.1. Market Revenue Forecast by Product
11.2.2. Market Revenue Forecast by Coating
11.2.3. Market Revenue Forecast by Raw Material
11.2.4. UK
11.2.4.1. Market Revenue Forecast
11.2.5. Germany
11.2.5.1. Market Revenue Forecast
11.2.6. France
11.2.6.1. Market Revenue Forecast
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product
11.3.2. Market Revenue Forecast by Coating
11.3.3. Market Revenue Forecast by Raw Material
11.3.4. China
11.3.4.1. Market Revenue Forecast
11.3.5. India
11.3.5.1. Market Revenue Forecast
11.3.6. Japan
11.3.6.1. Market Revenue Forecast
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast
11.4. LATAM
11.4.1. Market Revenue Forecast by Product
11.4.2. Market Revenue Forecast by Coating
11.4.3. Market Revenue Forecast by Raw Material
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product
11.5.2. Market Revenue Forecast by Coating
11.5.3. Market Revenue Forecast by Raw Material
11.5.4. GCC
11.5.4.1. Market Revenue Forecast
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast

Chapter 12. Company Profiles

12.1. Abbott
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin
12.1.4. Recent Developments and Strategies
12.2. AngioDynamicis Inc
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin
12.2.4. Recent Developments and Strategies
12.3. Asahi Intecc, Co Ltd
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin
12.3.4. Recent Developments and Strategies
12.4. B. Braun Melsungen AG
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin
12.4.4. Recent Developments and Strategies
12.5. Boston Scientific Corporation
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin
12.5.4. Recent Developments and Strategies
12.6. Cook Group
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin
12.6.4. Recent Developments and Strategies
12.7. Cardinal Health
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin
12.7.4. Recent Developments and Strategies
12.8. Medtronic
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin
12.8.4. Recent Developments and Strategies
12.9. Olympus Corporation
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin
12.9.4. Recent Developments and Strategies
12.10. Stryker Corporation
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin
12.10.4. Recent Developments and Strategies
12.11. Terumo Corporation
12.11.1. Company Overview, Business Information, Regional Presence
12.11.2. Product Portfolio Analysis
12.11.2.1. Product Details, Specification, Application
12.11.3. Revenue, Price, and Gross Margin
12.11.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : According to Precedence Research, The global guidewires market size was valued USD 2.95 billion in 2025 and expected to reach over USD 5 billion by the end of 2035.

Answer : The global guidewires market is projected to garner growth at a CAGR of 5.42% over the forecast period 2026 to 2035.

Answer : Growing incidences of target diseases across the globe is major factor driving growth of the global guidewires market. In addition to this, key players operating in the global industry are focusing on the launches of the advanced products which is propelling the target industry market in the near future.

Answer : North America dominated the global market with a market share of more than 30%.

Answer : The major companies functioning in the worldwide guidewires market are Olympus Corporation, B. Braun Melsungen AG, Abbott, Asahi Intecc, Co Ltd, Medtronic, Boston Scientific Corporation, Terumo Corporation, Stryker Corporation, Cook Group, AngioDynamicis Inc, and Cardinal Health among others.